US Patent 7662408 Sustained-release preparations
Patent 7662408 was granted and assigned to Takeda Pharmaceutical Company on February, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+259 characters)
Article
Patent abstract
A sustained release preparation comprising a combination of a microcapsule which gradually releases a GnRH agonist or a salt thereof for a long term, and a microcapsule which gradually releases a GnRH agonist or a salt thereof for a short term.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Kazuhiro Saito0
Tetsuo Hoshino0
Tomomichi Futo0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07662408 Sustained-release preparations US Patent 7662408 Sustained-release preparations
Infobox
Patent Number
07662408
Patent Number
7662408
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07662408 Sustained-release preparations
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07662408
Date of patent
February 16, 2010
Patent application number
10530186
Date Filed
February 9, 2005
Patent primary examiner
Find more entities like US Patent 7662408 Sustained-release preparations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.